Home・Aandelen Lijst・Baxter International Inc

Baxter International Inc

Gesloten

SectorGezondheidszorg

26.72 -1.44

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

26.58

Max

27.09

Belangrijke statistieken
By Trading Economics
Inkomsten	141M 126M
Verkoop	259M 3B
EPS	0.56
Dividendrendement	0.73
Winstmarge	4.257
Werknemers	37,500
EBITDA	177M 474M

Aanbevelingen
By TipRanks
Aanbevelingen	Neutraal
12 Maanden Prognose	-3.11% downside

Dividenden
By Acuity
Dividendrendement Sectorgemiddelde	0.73% 2.22%
Volgende Winsten	29 okt 2026
Volgende dividenddatum	1 okt 2026
Volgende Ex Dividend datum	28 aug 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	2.3B 14B
Vorige openingsprijs	28.16
Vorige sluitingsprijs	26.72

Nieuwssentiment

By Acuity

29%

71%

104 / 340 Rangschikking in Healthcare

Baxter International Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

13 aug 2026, 19:46 UTC

News

Baxter International recalls Duo-Vent Solution Set lots due to air bubble risks. Shares are trading higher since Wednesday's close despite the recall announcement.

12 aug 2026, 23:46 UTC

Baxter International Inc shares are higher in after-market trading, supported by recent inflation data that may influence Federal Reserve interest rate decisions.

11 aug 2026, 23:06 UTC

Baxter International Inc. shares traded roughly flat in after-market hours, reflecting a minor decline from earlier highs amid strong gains over the past month.

10 aug 2026, 23:16 UTC

Baxter International Inc shares are lower in after-market trading. No specific news was identified to explain this movement amid rising U.S. Treasury yields.

7 aug 2026, 23:51 UTC

Baxter International Inc shares are lower in after-market hours, retracing from earlier gains amid broader market sentiment influenced by a declining unemployment rate.

6 aug 2026, 19:36 UTC

Baxter International Inc. shares are lower today, with no specific news identified to explain the movement. The stock remains near its one-month range.

5 aug 2026, 20:01 UTC

Baxter International Inc shares are lower today, continuing a downward trend. The stock remains above its 20-day moving average despite recent declines.

4 aug 2026, 22:51 UTC

News

Baxter International shares are lower in after-market hours following the announcement of Interim CFO Anita Zielinski's resignation, effective September 15, 2026.

3 aug 2026, 23:02 UTC

Baxter International Inc shares are trading lower in after-market hours. Broader market volatility contributed to this decline without any specific company news.

31 jul 2026, 23:46 UTC

Baxter International shares are lower in after-market trading, following a brief session rise. Rising U.S. Treasury yields and crude oil prices heighten inflation concerns.

30 jul 2026, 23:21 UTC

Baxter International Inc shares are lower in after-market trading, reflecting unusual volatility despite strong performance over the past month.

29 jul 2026, 22:02 UTC

Baxter International Inc. shares are lower in after-market trading, mirroring the broader market's decline amid geopolitical tensions and inflation concerns.

28 jul 2026, 22:41 UTC

Baxter International Inc shares rose in after-market trading, continuing a trend of higher daily closes and remaining above the 20-day moving average.

27 jul 2026, 19:21 UTC

News

Baxter International shares are higher as TD Cowen raises the price target to $24.00, reflecting positive sentiment in the Health Care Equipment sector.

24 jul 2026, 19:02 UTC

Baxter International Inc shares are higher, reflecting market response to a decline in crude oil prices that eased inflationary pressures.

22 jul 2026, 19:56 UTC

News

Baxter International faces scrutiny over weak growth and declining earnings, contributing to lower shares amid broader weakness in the Health Care Equipment sector.

21 jul 2026, 23:01 UTC

Baxter International Inc. shares declined in after-hours trading, reflecting a weak performance despite a slight recovery from earlier session lows.

20 jul 2026, 23:02 UTC

Baxter International Inc shares are higher in after-market trading, reaching 1.27% above Monday's close and near the upper end of their one-month range.

Peer Vergelijking

Prijswijziging

Baxter International Inc Prognose

Koersdoel

By TipRanks

-3.11% neerwaarts potentieel

12 Maanden Prognose

Gemiddelde 25.9 USD -3.11%

Hoogste 29 USD

Laagste 21 USD

Gebaseerd op 10 Wall Street-analisten die 12-maands prijsdoelen bieden voor Baxter International Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Neutraal

10 ratings

Buy

Hold

Sell

Gebaseerd op 10 analisten die aandelenratings hebben gegeven aan Baxter International Inc - Dist in de afgelopen 3 maanden.

Sentiment

By Acuity

104 / 340 Rangschikking in Gezondheidszorg

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Baxter International Inc

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies. The company's products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products; and a collaborative research agreement with Miromatrix Medical Inc. aiming to advance care for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.